| 3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytes M Campisi, Y Shin, T Osaki, C Hajal, V Chiono, RD Kamm Biomaterials 180, 117-129, 2018 | 632 | 2018 |
| Suppression of STING associated with LKB1 loss in KRAS-driven lung cancer S Kitajima, E Ivanova, S Guo, R Yoshida, M Campisi, SK Sundararaman, ... Cancer discovery 9 (1), 34-45, 2019 | 363 | 2019 |
| MicroRNA delivery through nanoparticles SWL Lee, C Paoletti, M Campisi, T Osaki, G Adriani, RD Kamm, C Mattu, ... Journal of Controlled Release 313, 80-95, 2019 | 322 | 2019 |
| Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses I Cañadas, R Thummalapalli, JW Kim, S Kitajima, RW Jenkins, ... Nature medicine 24 (8), 1143-1150, 2018 | 272 | 2018 |
| 3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade AR Aref, M Campisi, E Ivanova, A Portell, D Larios, BP Piel, N Mathur, ... Lab on a Chip 18 (20), 3129-3143, 2018 | 240 | 2018 |
| In vitro microfluidic models for neurodegenerative disorders T Osaki, Y Shin, V Sivathanu, M Campisi, RD Kamm Advanced healthcare materials 7 (2), 1700489, 2018 | 152 | 2018 |
| Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity NR Mahadevan, EH Knelson, JO Wolff, A Vajdi, M Saigí, M Campisi, ... Cancer discovery 11 (8), 1952-1969, 2021 | 123 | 2021 |
| Modeling nanocarrier transport across a 3D in vitro human blood‐brain–barrier microvasculature SWL Lee, M Campisi, T Osaki, L Possenti, C Mattu, G Adriani, RD Kamm, ... Advanced healthcare materials 9 (7), 1901486, 2020 | 85 | 2020 |
| In vitro models of molecular and nano-particle transport across the blood-brain barrier C Hajal, M Campisi, C Mattu, V Chiono, RD Kamm Biomicrofluidics 12 (4), 2018 | 74 | 2018 |
| Suppression of STING associated with LKB1 loss in KRAS-driven lung cancer. Cancer Discov. 2019; 9: 34–45. doi: 10.1158/2159-8290 S Kitajima, E Ivanova, S Guo, R Yoshida, M Campisi, SK Sundararaman, ... CD-18-0689.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 64 | |
| Tumor-derived cGAMP regulates activation of the vasculature M Campisi, SK Sundararaman, SE Shelton, EH Knelson, NR Mahadevan, ... Frontiers in Immunology 11, 2090, 2020 | 53 | 2020 |
| Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes S Sengupta, S Das, AC Crespo, AM Cornel, AG Patel, NR Mahadevan, ... Nature cancer 3 (10), 1228-1246, 2022 | 44 | 2022 |
| MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer S Kitajima, T Tani, BF Springer, M Campisi, T Osaki, K Haratani, M Chen, ... Cancer Cell 40 (10), 1128-1144. e8, 2022 | 43 | 2022 |
| Activation of tumor-cell STING primes NK-cell therapy EH Knelson, EV Ivanova, M Tarannum, M Campisi, PH Lizotte, MA Booker, ... Cancer immunology research 10 (8), 947-961, 2022 | 38 | 2022 |
| A robust vasculogenic microfluidic model using human immortalized endothelial cells and Thy1 positive fibroblasts Z Wan, S Zhang, AX Zhong, SE Shelton, M Campisi, SK Sundararaman, ... Biomaterials 276, 121032, 2021 | 34 | 2021 |
| ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer I Mota, E Patrucco, C Mastini, NR Mahadevan, TC Thai, E Bergaggio, ... Nature Cancer 4 (7), 1016-1035, 2023 | 21 | 2023 |
| TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity T Tani, H Mathsyaraja, M Campisi, ZH Li, K Haratani, CG Fahey, K Ota, ... Cancer Discovery 14 (5), 752-765, 2024 | 18 | 2024 |
| 3D Self-Organized Human Blood–Brain Barrier in a Microfluidic Chip M Campisi, SH Lim, V Chiono, RD Kamm Programmed Morphogenesis: Methods and Protocols, 205-219, 2021 | 18 | 2021 |
| MET-induced CD73 restrains STING-mediated immunogenicity of EGFR-mutant lung cancer R Yoshida, M Saigi, T Tani, BF Springer, H Shibata, S Kitajima, ... Cancer research 82 (21), 4079-4092, 2022 | 17 | 2022 |
| Engineered microphysiological systems for testing effectiveness of cell-based cancer immunotherapies M Campisi, SE Shelton, M Chen, RD Kamm, DA Barbie, EH Knelson Cancers 14 (15), 3561, 2022 | 10 | 2022 |
Valeria ChionoPolitecnico di TorinoEmail verificata su polito.it
